Evidence map›Paper›PMID 42211202›Full record

ArticleInternational journal of ophthalmology2026

Visual outcomes of implantable Collamer lens and laser-assisted

Tsetsegjargal Baasanjav, Davaalkham Dambadarjaa, Baasankhuu Jamyanjav, Uranchimeg Davaatseren

Abstract read
In one paragraph

Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tsetsegjargal BaasanjavDepartment of Ophthalmology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 15160, Mongolia.
Davaalkham DambadarjaaDepartment of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar 15160, Mongolia.
Baasankhuu JamyanjavBolor-Melmii Eye Hospital, Ulaanbaatar 15160, Mongolia.
Uranchimeg DavaatserenDepartment of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar 15160, Mongolia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo compare the clinical outcomes of the current V4c model of the myopic implantable Collamer lens (ICL) with those of laser

methodsThis prospective, non-randomized study enrolled participants who underwent either LASIK or implantation of the ICL V4c at Bolor Melmii Eye Hospital. In the LASIK group, participants received Intralase LASIK (I-LASIK) using the Intralase FS-200 femtosecond laser and the MEL-80 excimer laser. Each group comprised the same number of participants and eyes (38 participants, 73 eyes).

resultsA total of 146 eyes from 76 participants were analyzed. Among the LASIK group, 76.3% were female, with a mean age at surgery of 29.76±5.95y (range, 20-43y). In the ICL group, 92.1% were female, with a mean age of 31.59±8.32y (range, 20-49y). Preoperative best-corrected visual acuity (BCVA) did not differ significantly between the LASIK and ICL groups (

conclusionBoth LASIK and ICL implantation leads to significant improvements in visual outcomes, with early postoperative gains observed in both groups. However, the ICL group demonstrates greater long-term improvement in BCVA compared to the LASIK group, particularly among participants with higher degrees of myopia. Visual outcomes in both groups stabilized by 6mo postoperatively.

Indexed as

best corrected visual acuityimplantable Collamer lenslaser in situ keratomileusismanifest refractive spherical equivalent

Identifiers

PMID42211202
PMCPMC13213187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.